Biological impact and therapeutic potential of a novel camptothecin derivative (FLQY2) in pancreatic cancer through inactivation of the PDK1/AKT/mTOR pathway

Authors: Wenchao Wang, Haonan Xiong, Lei Li, Xialin Hu, Wenya Zhuang, Jiangtao Li, Xuanrong Sun, Yanlei Yu, Yuanquan Yu, Yinghao Guo, Yihang Wang, Ruojiong Wang, Hong Wang, QingYong Li 

https://doi.org/10.1016/j.bioorg.2024.107436, 2024

Published in: Bioorganic Chemistry

Tags: Camptothecin; FLQY2; Organoids; Topoisomerase I; Signaling pathway; Pancreatic cancer